Quality Systems

Articles

Brazil's generic-drug market is growing steadily.

Report from Brazil March 2012

The Asian nation is strategizing to take the lead over its regional competitors in pharmaceutical exports.

Report from India

Angie Drakulich was editorial director of Pharmaceutical Technology.

As part of the BRIC bloc with Russia, India, and China, Brazil is one of the world's leading emerging economies and is also considered by IMS Health to be one of seven pharmerging nations, which also include Mexico, Turkey, and South Korea.

Global Healthcare on the Ground: Brazil's Development Bank Leader Discusses the Country's Pharma Future

Jane Wan is a freelance writer based in Singapore.

Packaging is indeed headed to be a lead sector in the Asian pharmaceutical environment, but certain challenges must first be overcome.

Report from Asia

Sean Milmo is a freelance writer based in Essex, UK.

Russia is aiming to provide an alternative to China and India for drug manufacturing, including APIs.

Report from Russia

In an effort to balance bilateral trade, India is urging China to increase Indian pharmaceutical imports.

Regulatory Roundup: USP Expands Presence in India

Growth and change in Brazil and Mexico offer key opportunities for the region's pharmaceutical industry.

Report from Latin America

USP and the Brazilian National Agency of Sanitary Surveillance are teaming up to develop joint education activities for professionals involved in formulating and using pharmacopeial monograph standards in Brazil.

USP and Brazil Partner on Public Health Education

Contract manufacturing organizations throughout Asia are increasing their capabilities to meet market demand and attract foreign investment and partnerships.

Regulatory/GMP Compliance, Emerging Markets